The inhibition of PARP-1 is helpful in the treatment of cancers because it causes accumulation of DNA damage and synthetic lethality of cancer cells presenting defects in homologous recombination (HR)-mediated DNA repair machinery [72]. This evidence concerns the gene PARP1 and cancer.